HOME Top Market Reports Molecular Biology Enzymes and Kits & Reagents Market by Product (Kits & Reagents, Enzymes), Application (PCR, Sequencing, Cloning, Epigenetics), End User (Academic & Research Institutes, Hospitals & Diagnostic Centers), and Region - Global Forecast to 2022

Molecular Biology Enzymes and Kits & Reagents Market by Product (Kits & Reagents, Enzymes), Application (PCR, Sequencing, Cloning, Epigenetics), End User (Academic & Research Institutes, Hospitals & Diagnostic Centers), and Region - Global Forecast to 2022

By: marketsandmarkets.com
Publishing Date: October 2017
Report Code: BT 2612

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


Molecular biology enzymes are natural proteins produced by living organisms (animals, plants, and bacteria) and are highly selective biochemical catalysts. Molecular biology reagents are chemicals used in molecular biology reactions to optimize the workflow. The global molecular biology enzymes and kits & reagents market is projected to reach USD 13.60 Billion by 2022 from USD 5.69 Billion in 2016, at a CAGR of 15.8% during the forecast period. Base year considered for the report is 2016. Forecast period considered for the report is 2017–2022.

Growth in the molecular biology enzymes and kits & reagents market is driven by factors such as increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of infectious diseases & genetic disorders. However, limited reimbursements for genetic testing is expected to restrain the growth of this market during the forecast period.

Objectives of the Study

  • To define and measure the global molecular biology enzymes and kits & reagents market on the basis of product, application, end user, and region
  • To identify key micromarkets and their drivers within the global molecular biology enzymes and kits & reagents market, which are expected to offer impressive growth opportunities in the coming years
  • To identify trends and opportunities for stakeholders in the market and provide details of the competitive landscape for major market leaders
  • To provide detailed information regarding the major factors influencing market growth (drivers, restraints, challenges, and opportunities)
  • To forecast the size of the market segments with respect to four main regions, namely, North America (US and Canada), Europe (Germany, UK, France, and Rest of Europe), Asia Pacific (China, Japan, India, and Rest of APAC), and the Rest of the World (Latin America and Middle East & Africa)
  • To analyze the market structure and profile key players in the global molecular biology enzymes and kits & reagents market and comprehensively evaluate their core competencies
  • To track and analyze competitive landscape such as market share analysis and competitive leadership

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global molecular biology enzymes and kits & reagents market and estimate the size of other dependent submarkets. Various secondary sources such as, Biotechnology and Biological Sciences Research Council, European Federation of Biotechnology, Genome Canada, National Human Genome Research Institute, World Health Organization, Federation of Asian and Oceanian Biochemists and Molecular Biologists, World Intellectual Property Organization, Press Releases, directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

Molecular Biology Enzymes, Kits, & Reagents Market

To know about the assumptions considered for the study, download the pdf brochure

The major players in the global molecular biology enzymes and kits & reagents market are Thermo Fisher (US), Merck (Germany), Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), and Molecular Biology Resources (US).

Target Audience:

  • Molecular Biology Enzymes and Kits & Reagents Manufacturers and Vendors
  • Associations Related to Molecular Biology Enzymes and Kits & Reagents
  • Contract Research Organizations (CROs)
  • Research Institutes and Academic Centers
  • Pharmaceutical and Biopharmaceutical Companies
  • Business Research and Consulting Service Providers
  • Venture Capitalists

Scope of the Report:

The research report categorizes the molecular biology enzymes and kits & reagents market into the following segments and subsegments:

Molecular Biology Enzymes and Kits & Reagents Market, by Product

  • Kits & Reagents
  • Enzymes
    • Polymerases
    • Ligases
    • Restriction Endonucleases
    • Reverse Transcriptases
    • Phosphatases
    • Proteases and Proteinases
    • Other Enzymes

Molecular Biology Enzymes and Kits & Reagents Market, by Application

  • PCR
  • Sequencing
  • Cloning
  • Epigenetics
  • Restriction Digestion
  • Synthetic Biology
  • Other Applications*

Molecular Biology Enzymes and Kits & Reagents Market, by End User

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology companies
  • Hospitals & Diagnostic Centers
  • Other End Users**

Molecular Biology Enzymes and Kits & Reagents Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • RoW
    • Latin America
    • Middle East and Africa

* Other applications include mutagenesis, in vitro transcription, and molecular labeling & detection.
**Other end users include contract research organizations (CROs), food & beverage companies, and forensics.

Available customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Company Information

  • Detailed analysis and profiling of additional market players (up to 3)

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Research Design
    2.2 Research Approach
           2.2.1 Secondary Research
                    2.2.1.1 Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Primary Sources
    2.3 Market Size Estimation
    2.4 Market Data Validation and Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 29)

4 Premium Insights (Page No. - 33)
    4.1 Molecular Biology Enzymes and Kits & Reagents: Market Overview
    4.2 Molecular Biology Enzymes and Kits & Reagents in Asia Pacific Market, By Application and Country, 2017
    4.3 Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2017 vs 2022
    4.4 Geographic Snapshot of the Molecular Biology Enzymes and Kits & Reagents Market

5 Market Overview (Page No. - 37)
    5.1 Introduction
    5.2 Drivers
           5.2.1 Increased Research Activities and R&D Investments in the Life Science Industry
           5.2.2 Growing Number of Genome Projects
           5.2.3 Technological Advancements in the Life Science Industry
           5.2.4 Rising Incidence of Infectious Diseases and Genetic Disorders
    5.3 Restraints
           5.3.1 Limited Reimbursements for Genetic Testing
    5.4 Opportunities
           5.4.1 Increased Use of Personalized Medicine
           5.4.2 Developing Countries Offer Significant Opportunities for the Market
    5.5 Challenges
           5.5.1 Privacy Issues Related to Genetic Information

6 Molecular Biology Enzymes and Kits & Reagents Market, By Product (Page No. - 43)
    6.1 Introduction
    6.2 Kits & Reagents
    6.3 Enzymes
           6.3.1 Polymerases
           6.3.2 Ligases
           6.3.3 Restriction Endonucleases
           6.3.4 Reverse Transcriptases
           6.3.5 Phosphatases
           6.3.6 Proteases and Proteinases
           6.3.7 Other Enzymes

7 Molecular Biology Enzymes and Kits & Reagents Market, By Application (Page No. - 51)
    7.1 Introduction
    7.2 Polymerase Chain Reaction
    7.3 Sequencing
    7.4 Cloning
    7.5 Epigenetics
    7.6 Restriction Digestion
    7.7 Synthetic Biology
    7.8 Other Applications

8 Molecular Biology Enzymes and Kits & Reagents Market, By End User (Page No. - 60)
    8.1 Introduction
    8.2 Academic & Research Institutes
    8.3 Pharmaceutical & Biotechnology Companies
    8.4 Hospitals & Diagnostic Centers
    8.5 Other End Users

9 Molecular Biology Enzymes and Kits & Reagents Market, By Region (Page No. - 67)
    9.1 Introduction
    9.2 North America
           9.2.1 Us
                    9.2.1.1 Increasing Funding for Genomics Research
                    9.2.1.2 Growth in the Number of Pharmaceutical and Biotechnology Companies
                    9.2.1.3 Favorable Reimbursement Scenario for Molecular Diagnostics and Growing Prevalence of Target Indications in the US
           9.2.2 Canada
                    9.2.2.1 Investments in Research Projects
    9.3 Europe
           9.3.1 Germany
                    9.3.1.1 Presence of A Large Number of Academic and Research Institutes
                    9.3.1.2 Increasing Pharmaceutical R&D
                    9.3.1.3 Venture Capital Investments in Germany
           9.3.2 Uk
                    9.3.2.1 Funding for Research Activities
                    9.3.2.2 Increasing Adoption of Molecular Diagnostics for Cancer Diagnosis in the Uk
                    9.3.2.3 The 100,000 Genomes Project
           9.3.3 France
                    9.3.3.1 Presence of A Large Cancer Patient Population
                    9.3.3.2 Genomic Medicine 2025 Plan
           9.3.4 RoE
                    9.3.4.1 Large Biotechnology and Pharmaceutical Industry in Italy
                    9.3.4.2 Growth in the Spanish Biotechnology Industry
    9.4 Asia Pacific
           9.4.1 China
                    9.4.1.1 Increasing Government Interest in Biomedical and Biotechnology Industries
                    9.4.1.2 Outsourcing of Clinical Research Activities to China
           9.4.2 Japan
                    9.4.2.1 Involvement of Industry Players in the Japanese Market
                    9.4.2.2 Focus on Cancer Research and Treatment
           9.4.3 India
                    9.4.3.1 Growing Pharmaceutical Industry in India, Government Initiatives
                    9.4.3.2 Development of Bio-Clusters to Propel the Biotechnology Industry in India
           9.4.4 RoAPAC
                    9.4.4.1 The Genome Asia 100k Initiative
                    9.4.4.2 Alliances and Partnerships in Molecular Biology Applications to Boost the Australian Market
    9.5 Rest of the World (RoW)
           9.5.1 Investments in Research & Innovation Centers and Conferences & Workshops in Brazil
           9.5.2 Rising Prevalence of Conditions Involving Molecular Diagnostics in Africa

10 Competitive Landscape (Page No. - 113)
     10.1 Introduction
     10.2 Market Share Analysis, 2016

11 Company Profiles (Page No. - 115)
(Business Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments)*
     11.1 Thermo Fisher Scientific, Inc.
     11.2 Merck KGaA
     11.3 Promega Corporation
     11.4 New England Biolabs
     11.5 Illumina, Inc.
     11.6 Takara Bio, Inc.
     11.7 Qiagen N.V.
     11.8 Agilent Technologies, Inc.
     11.9 F. Hoffmann-La Roche Ltd
     11.10 Bio Basic Inc.
     11.11 Jena Bioscience GmbH
     11.12 Molecular Biology Resources, Inc.

*Details on Business Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 166)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Introducing RT: Real-Time Market Intelligence
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details


List of Tables (88 Tables)

Table 1 Government Funding for Personalized Medicine
Table 2 Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 3 Molecular Biology Kits & Reagents Market, By Region, 2015–2022 (USD Million)
Table 4 Molecular Biology Enzymes Market, By Type, 2015–2022 (USD Million)
Table 5 Molecular Biology Enzymes Market, By Region, 2015–2022 (USD Million)
Table 6 Molecular Biology Enzymes Market for Polymerases, By Region, 2015–2022 (USD Million)
Table 7 Molecular Biology Enzymes Market for Ligases, By Region, 2015–2022 (USD Million)
Table 8 Molecular Biology Enzymes Market for Restriction Endonucleases, By Region, 2015–2022 (USD Million)
Table 9 Molecular Biology Enzymes Market for Reverse Transcriptases, By Region, 2015–2022 (USD Million)
Table 10 Molecular Biology Enzymes Market for Phosphatases, By Region, 2015–2022 (USD Million)
Table 11 Molecular Biology Enzymes Market for Proteases and Proteinases, By Region, 2015–2022 (USD Million)
Table 12 Molecular Biology Enzymes Market for Other Enzymes, By Region, 2015–2022 (USD Million)
Table 13 Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 14 Molecular Biology Enzymes and Kits & Reagents Market for PCR, By Region, 2015–2022 (USD Million)
Table 15 Molecular Biology Enzymes and Kits & Reagents Market for Sequencing, By Region, 2015–2022 (USD Million)
Table 16 Molecular Biology Enzymes and Kits & Reagents Market for Cloning, By Region, 2015–2022 (USD Million)
Table 17 Molecular Biology Enzymes and Kits & Reagents Market for Epigenetics, By Region, 2015–2022 (USD Million)
Table 18 Molecular Biology Enzymes and Kits & Reagents Market for Restriction Digestion, By Region, 2015–2022 (USD Million)
Table 19 Molecular Biology Enzymes and Kits & Reagents Market for Synthetic Biology, By Region, 2015–2022 (USD Million)
Table 20 Molecular Biology Enzymes and Kits & Reagents Market for Other Applications, By Region, 2015–2022 (USD Million)
Table 21 Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 22 Academic & Research Institutes Market, By Region, 2015–2022 (USD Million)
Table 23 Pharmaceutical & Biotechnology Companies Market, By Region, 2015–2022 (USD Million)
Table 24 Hospitals & Diagnostic Centers Market, By Region, 2015–2022 (USD Million)
Table 25 Other End Users Market, By Region, 2015–2022 (USD Million)
Table 26 North America: Molecular Biology Enzymes and Kits & Reagents Market, By Country, 2015–2022 (USD Million)
Table 27 North America: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 28 North America: Enzymes Market, By Type, 2015–2022 (USD Million)
Table 29 North America: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 30 North America: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 31 Funding for Genomics-Related Projects
Table 32 US: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 33 US: Enzymes Market, By Type, 2015–2022 (USD Million)
Table 34 US: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 35 US: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 36 Canada: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 37 Canada: Enzymes Market, By Type, 2015-2022 (USD Million)
Table 38 Canada: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 39 Canada: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 40 Europe: Molecular Biology Enzymes and Kits & Reagents Market, By Country, 2015–2022 (USD Million)
Table 41 Europe: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 42 Europe: Enzymes Market, By Type, 2015–2022 (USD Million)
Table 43 Europe: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 44 Europe: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 45 Germany: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 46 Germany: Enzymes Market, By Type, 2015–2022 (USD Million)
Table 47 Germany: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 48 Germany: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 49 UK: Number of Molecular Diagnostic Tests Conducted Between 2011 and 2014, By Cancer Type
Table 50 UK: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 51 UK: Enzymes Market, By Type, 2015–2022 (USD Million)
Table 52 UK: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 53 UK: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 54 France: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 55 France: Enzymes Market, By Type, 2015–2022 (USD Million)
Table 56 France: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 57 France: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 58 RoE: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 59 RoE: Molecular Biology Enzymes Market, By Type, 2015–2022 (USD Million)
Table 60 RoE: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 61 RoE: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 62 APAC: Molecular Biology Enzymes and Kits & Reagents Market, By Country, 2015–2022 (USD Million)
Table 63 APAC: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 64 APAC: Molecular Biology Enzymes Market, By Type, 2015–2022 (USD Million)
Table 65 APAC: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 66 APAC: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 67 China: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 68 China: Molecular Biology Enzymes Market, By Type, 2015–2022 (USD Million)
Table 69 China: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 70 China: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 71 Japan: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 72 Japan: Molecular Biology Enzymes Market, By Type, 2015–2022 (USD Million)
Table 73 Japan: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 74 Japan: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 75 India: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 76 India: Molecular Biology Enzymes Market, By Type, 2015–2022 (USD Million)
Table 77 India: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 78 India: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 79 RoAPAC: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 80 RoAPAC: Molecular Biology Enzymes Market, By Type, 2015–2022 (USD Million)
Table 81 RoAPAC: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 82 RoAPAC: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 83 Hiv Infections and Aids-Related Deaths in the Middle East and Africa, 2015
Table 84 RoW: Molecular Biology Enzymes and Kits & Reagents Market, By Region, 2015–2022 (USD Million)
Table 85 RoW: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 86 RoW: Molecular Biology Enzymes Market, By Type, 2015–2022 (USD Million)
Table 87 RoW: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 88 RoW: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)


List of Figures (33 Figures)

Figure 1 Research Design: Global Molecular Biology Enzymes and Kits & Reagents Market
Figure 2 Sampling Frame: Primary Research
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Key Industry Insights
Figure 5 Bottom-Up Approach
Figure 6 Top-Down Approach
Figure 7 Data Triangulation
Figure 8 Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2017
Figure 9 Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2017 vs 2022
Figure 10 Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2017 vs 2022
Figure 11 Geographic Snapshot of the Molecular Biology Enzymes and Kits & Reagents Market
Figure 12 Increase in Research Activities in the Life Science Industry is A Key Growth Driver of the Market
Figure 13 Academic & Research Institutes Segment to Dominate the Asia Pacific Molecular Biology Enzymes and Kits & Reagents Market in 2017
Figure 14 PCR Will Continue to Dominate the Molecular Biology Enzymes and Kits & Reagents Market in 2022
Figure 15 Asia Pacific to Register the Highest CAGR During the Forecast Period
Figure 16 Molecular Biology Enzymes and Kits & Reagents Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Kits & Reagents Segment to Dominate the Market in 2017
Figure 18 The PCR Application Segment to Dominate the Market in 2017
Figure 19 Academic & Research Institutes to Dominate the Market in 2017
Figure 20 North America Estimated to Be the Largest Regional Market for Molecular Biology Enzymes and Kits & Reagents in 2017
Figure 21 North American Molecular Biology Enzymes and Kits & Reagents Market Snapshot
Figure 22 Number of New Pharmaceutical and Biotechnology Companies in the Us, 2014–2016
Figure 23 European Molecular Biology Enzymes and Kits & Reagents Market Snapshot
Figure 24 APAC Molecular Biology Enzymes and Kits & Reagents Market Snapshot
Figure 25 RoW: Molecular Biology Enzymes and Kits & Reagents Market Snapshot
Figure 26 Global Molecular Biology Enzymes and Kits & Reagents Market Share Analysis, By Key Player, 2016
Figure 27 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 28 Merck KGaA: Company Snapshot
Figure 29 Illumina, Inc.: Company Snapshot
Figure 30 Takara Bio, Inc.: Company Snapshot
Figure 31 Qiagen N.V.: Company Snapshot
Figure 32 Agilent Technologies, Inc.: Company Snapshot
Figure 33 F. Hoffmann-La Roche Ltd: Company Snapshot

The global molecular biology enzymes and kits & reagents market is projected to reach USD 13.60 Billion by 2022 from USD 6.52 Billion in 2017, at a CAGR of 15.8% during the forecast period. The growth of this market is majorly driven by factors such as increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of infectious diseases & genetic disorders.

The molecular biology enzymes and kits & reagents market is segmented on the basis of product, application, end user, and region. On the basis of product, the global market is segmented into enzymes and kits & reagents. The enzymes market is further subsegmented into polymerases, ligases, restriction endonucleases, reverse transcriptases, phosphatases, proteases & proteinases, and other enzymes (T4 polynucleotide kinases, exonuclease III, methyltransferases, glycosylases, and agarase). The kits & reagents segment is expected to account for the largest share and register the highest CAGR during the forecast period. This can be primarily attributed to the requirement of repeat purchase of these single-use products and increasing drug research in the pharmaceutical industry.

Based on application, the market is segmented into polymerase chain reaction (PCR), sequencing, cloning, epigenetics, restriction digestion, synthetic biology, and other applications (mutagenesis, in vitro transcription, and molecular labeling & detection). The sequencing segment is expected to grow at the highest rate during the forecast period primarily due to the increasing DNA sequencing with growth in genomic research, rapid technological advancements, decreasing costs of sequencing, and growing use of whole-genome sequencing and personalized genome sequencing. In 2017, the PCR segment is expected to hold the largest share owing to high demand for PCR equipment by a majority of end users.

Based on end user, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & diagnostic centers, and other end users (contract research organizations, food & beverage companies, and forensic agencies). The hospitals & diagnostic centers segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing adoption of molecular diagnostics and the rising prevalence of disorders that require molecular biology assays (that use kits) for diagnosis.

The geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the increasing research funding for genomics research, rising number of pharmaceutical and biotechnology companies, increasing prevalence of conditions involving molecular diagnostics, and rising investments in research projects in Canada.

Molecular Biology Enzymes, Kits, & Reagents Market

The limited reimbursements for genetic testing is expected to restrain the growth of this market during the forecast period.

The major players in this market include Thermo Fisher (US), Merck (Germany), Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), and Molecular Biology Resources (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo